Alterity Therapeutics (ATHE) has released an update.
Alterity Therapeutics has announced the successful passage of all resolutions at their Extraordinary General Meeting, signaling possible directional shifts or strategies that could impact investors. The meeting, involving shareholders’ votes, may influence the company’s future operations and market performance.
For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.
